Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 31, 2025 | MethodSense CEO to Present at MEDICA 2025 | Understanding Getting Medical Technologies Through Today’s FDA and EU MDR Attendees will gain clarity on the different systems, evolving rules, practical approaches to achieving compliance, and how regulatory changes will impact business pl... |
| Oct 17, 2025 | MethodSense CEO to Present at American Medical Device Summit 2025 | Presentation on AI Regulation in Medical Technologies for Manufacturers, Regulators and Stakeholders Attendees will gain clarity on aligning with evolving rules, practical steps for compliance, regulatory changes that will impact business p... |
| Aug 21, 2025 | MethodSense Announces Scalable, Intelligent Platform to Accelerate MedTech Innovation | Company creates an integrated approach reinforcing leadership role in regulatory compliance At MethodSense, we believe regulatory excellence should act as an accelerant, not an obstacle, to innovation. When compliance is clear, more lives a... |
| Aug 7, 2025 | MethodSense Welcomes Medical Device Innovator Dr. Anna Galea as Senior Regulatory Strategist | Life science veteran to guide clients through complex submissions and accelerate development of AI/ML-enabled medical technologies MethodSense’s philosophy of embedding with each client team and treating their challenges as our own, mirrors... |
| Jul 23, 2025 | MethodSense Announces Growth Plans to Meet the Demands of a Rapidly Evolving Regulatory Landscape | With new leadership, platform innovation, and an AI-era focus, MethodSense is scaling its service offerings to help MedTech innovators meet regulatory demands. MethodSense is poised to become the regulatory platform partner for companies se... |
| Jul 2, 2025 | Tech Innovator Richard Holcomb Joins MethodSense as Chief Growth Officer | Richard Holcomb, MethodSense Chief Growth Officer Appointment strengthens MethodSense’s expansion strategy as the company accelerates into the AI-driven future of regulatory compliance... We’re entering the AI era of regulatory compliance. ... |
| Mar 5, 2025 | MethodSense Helps Medical Device Companies Meet FDA’s Tougher Draft Guidance for Pulse Oximeters | New FDA Draft Guidance for Pulse Oximeters New FDA Draft Guidance Raises the Bar on Pulse Oximeter Accuracy – MethodSense Leads the Way in Compliance, Clinical Validation, and Regulatory Strategy Manufacturers need to understand both the sc... |
Reviews 0
FAQ about LuminLogic
What has the press written about LuminLogic?
Parsers VC has collected 8 articles mentioning LuminLogic, among them “MethodSense CEO to Present at MEDICA 2025” (Oct 31, 2025) and “MethodSense CEO to Present at American Medical Device Summit 2025” (Oct 17, 2025).
Is LuminLogic still active?
LuminLogic is probably closed: its latest activity on Parsers VC dates from Mar 5, 2026.